hyposexual desire disorder
Showing 1 - 25 of >10,000
Hypoactive Sexual Desire Disorder Trial in Seoul (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 15, 2022
Female Sexual Interest/Arousal Disorder Trial in Castelldefels (Libicare, active control)
Not yet recruiting
- Female Sexual Interest/Arousal Disorder
- Libicare
- active control
-
Castelldefels, Barcelona, SpainProcare Health Iberia
Dec 1, 2022
Hypoactive Sexual Desire Disorder Trial in London (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
London, United KingdomImperial College Healthcare NHS Trust
Mar 9, 2022
Hypoactive Sexual Desire Disorder Trial in San Diego (Oral Testosterone Undecanoate)
Not yet recruiting
- Hypoactive Sexual Desire Disorder
- Oral Testosterone Undecanoate
-
San Diego, CaliforniaSan Diego Sexual Medicine
Oct 12, 2023
Sexual Desire Disorder Trial in Santa Monica (DLM - Test product)
Completed
- Sexual Desire Disorder
- DLM - Test product
-
Santa Monica, CaliforniaCitruslabs
Jan 5, 2022
Sexuality, Sexual Dysfunction, Sexual Desire Disorder Trial in Los Angeles (Vibrator)
Recruiting
- Sexuality
- +9 more
- Vibrator
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jul 18, 2022
Hypoactive Sexual Desire Disorder Trial in San Diego (sex therapy, flibanserin)
Terminated
- Hypoactive Sexual Desire Disorder
- sex therapy
- flibanserin
-
San Diego, CaliforniaSan Diego Sexual Medicine
Jun 8, 2022
Craving, Mastication Disorder, Memory Disorders Trial in Teresina (speech therapy for chewing + real tDCS)
Recruiting
- Craving
- +6 more
- speech therapy for chewing + real tDCS
-
Teresina, Piaui, BrazilHospital Universitário Do Piauí
Sep 15, 2021
Hypoactive Sexual Desire Disorder Trial in Chicago (Flibanserin, Placebo)
Unknown status
- Hypoactive Sexual Desire Disorder
- Flibanserin
- Placebo
-
Chicago, IllinoisUniversity of Chicago
Jan 15, 2021
Hypoactive Sexual Desire Disorder Trial in Bochum (Cognitive-behavioral treatment, Mindfulness-based treatment)
Unknown status
- Hypoactive Sexual Desire Disorder
- Cognitive-behavioral treatment
- Mindfulness-based treatment
-
Bochum, NRW, GermanyRuhr University Bochum
Oct 6, 2020
Hypoactive Sexual Desire Disorder (HSDD) Trial in United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal
Withdrawn
- Hypoactive Sexual Desire Disorder (HSDD)
- Placebo Vaginal Insert
- Prasterone 6.5 mg (0.50%) Vaginal Insert
-
Huntsville, Alabama
- +9 more
Jul 29, 2020
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal
Completed
- Hypoactive Sexual Desire Disorder
- Placebo Vaginal Insert
- Prasterone 6.5 mg (0.50%) Vaginal Insert
-
Huntsville, Alabama
- +68 more
Apr 7, 2021
Hypoactive Sexual Desire Disorder Trial in Canada, United States (testosterone gel, gel)
Completed
- Hypoactive Sexual Desire Disorder
- testosterone gel
- placebo gel
-
Birmingham, Alabama
- +148 more
Oct 27, 2021
Sexual Behavior, Sexual Orientation Conflict Disorder, Sexual Arousal Disorder Trial in Nasiriyah (H - Test)
Enrolling by invitation
- Sexual Behavior
- +4 more
- H - Test
-
Nasiriyah, Thi Qar, IraqNo name
Dec 11, 2020
Menopause, Metabolic Syndrome, Hypoactive Sexual Desire Disorder Trial in São Paulo (Female sexual function index questionnaire,
Completed
- Menopause
- +4 more
- Female sexual function index questionnaire
- +2 more
-
São Paulo, BrazilRua Maria José Pomar, 322 Apartamento 172 C
Dec 30, 2019
Brief Index of Sexual Functioning for Men
Not yet recruiting
- Sexual Dysfunction Male
- Questionnaire
- (no location specified)
Jul 17, 2023
Sexual Dysfunction, Sexual Abstinence, Sexual Desire Disorder Trial in Nasiriyah (JT Device)
Enrolling by invitation
- Sexual Dysfunction
- +9 more
- JT Device
-
Nasiriyah, Thi Qar, IraqHashim Talib Talib Hashim
Dec 5, 2020
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Bremelanotide, Placebo)
Completed
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Birmingham, Alabama
- +90 more
Mar 16, 2021
Hypoactive Sexual Desire Disorder, Female Sexual Dysfunction, Sexual Desire Disorder Trial in Russian Federation (BP101,
Completed
- Hypoactive Sexual Desire Disorder
- +2 more
- BP101
- Placebo
-
Barnaul, Russian Federation
- +19 more
Feb 10, 2020
Sexual Functioning Trial in London (Mindful compassion based on behavioural change taxonomy experimental group)
Completed
- Sexual Functioning
- Mindful compassion based on behavioural change taxonomy experimental group
-
London, United KingdomLondon Met university
Sep 14, 2023
Sexual Function Disturbances, IBD Trial (The Arabic version of The International Index of Erectile Function (IIEF-5), The Sexual
Not yet recruiting
- Sexual Function Disturbances
- Inflammatory Bowel Diseases
- The Arabic version of The International Index of Erectile Function (IIEF-5)
- +5 more
- (no location specified)
Jan 28, 2023
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Bremelanotide, Placebo)
Completed
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Birmingham, Alabama
- +90 more
Jan 26, 2021
Female Sexual Arousal Disorder, Female Sexual Dysfunction Trial (BZ371A 7.5 mg (1.5 ml), BZ371A 5.0 mg (1.0 ml), BZ371A 2.5 mg
Not yet recruiting
- Female Sexual Arousal Disorder
- Female Sexual Dysfunction
- BZ371A 7.5 mg (1.5 ml)
- +5 more
- (no location specified)
Oct 30, 2023
Hypoactive Sexual Desire Disorder Trial in London (Intrinsa Transdermal testosterone patch)
Completed
- Hypoactive Sexual Desire Disorder
- Intrinsa Transdermal testosterone patch
-
London, United Kingdom
- +2 more
Dec 13, 2019